V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190010650 | 190008260 | 1.88 | 34 | Palliative (P) | 2019-01-15 | 2019-01-16 | DOXORUBICIN | 1 | Y | DOXORUBICIN | 100561190 |
| 190010755 | 190008262 | 0 | 47.2 | Curative (C) | 2019-04-26 | 2019-09-08 | EURAMOS TRIAL | 02 | null | METHOTREXATE HIGH DOSE | 101847115 |
| 190010853 | 190008263 | 0 | 57.8 | Palliative (P) | 2020-12-16 | 2020-12-16 | Cisplatin + Radiotherapy | null | null | EW EUROEWING 2012 ARM B VDC | 100377460 |
| 190007264 | 190008265 | 0 | 36 | Curative (C) | 2021-08-04 | 2021-09-11 | DOXORUBICIN | null | null | DOXORUBICIN | 101834705 |
| 190009744 | 190008275 | 0 | 77 | Adjuvant (A) | 2016-06-30 | 2016-07-06 | DOXORUBICIN + METHOTREXATE | null | null | CAPECITABINE | 100054242 |
| 190009897 | 190008276 | 0 | 36 | null | 2019-12-19 | 2019-12-19 | CAPECITABINE + CARBOPLATIN | 02 | null | CYCLOPHOSPHAMIDE + TOPOTECAN | 101513878 |
| 190009910 | 190008277 | 1.67 | 82.15 | Curative (C) | 2016-04-29 | 2016-05-07 | Carboplatin + Paclitaxel (3 weekly) | 01 | N | CARBOPLATIN + PACLITAXEL | 101791109 |
| 190010117 | 190008280 | null | 101 | null | 2021-11-06 | 2021-11-08 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100494715 |
| 190010347 | 190008281 | 1.36 | 64 | Palliative (P) | 2017-07-30 | 2017-08-21 | PEMBROLIZUMAB | 02 | N | TRIAL | 100457965 |
| 190010358 | 190008282 | 1.52 | 35 | null | 2019-11-10 | 2020-11-09 | OST Euramos 1 Closed Trial - A | null | null | OST A | 100958431 |
| 190010459 | 190008283 | 1.68 | 83 | Curative (C) | 2019-03-16 | 2020-06-12 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101317669 |
| 190010554 | 190008284 | 1.85 | 71.7 | null | null | 2021-11-19 | Dacarbazine | 02 | null | NOT MATCHED | 101448429 |
| 190010755 | 190008286 | 1.72 | null | Neo-adjuvant (N) | 2019-10-07 | 2019-10-08 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101847115 |
| 190010853 | 190008287 | 0 | 35.8 | Curative (C) | 2020-12-28 | 2021-01-08 | Methotrexate High Dose (3g/m2) | 01 | null | METHOTREXATE | 100377460 |
| 190007264 | 190008289 | 0 | 56.4 | Adjuvant (A) | null | 2021-10-24 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 101834705 |
| 190010117 | 190008297 | 1.63 | 14.1 | Curative (C) | 2021-11-05 | 2021-11-08 | PEMBROLIZUMAB | 01 | N | EURAMOS TRIAL | 100494715 |
| 190010347 | 190008298 | 1.81 | 43.3 | Neo-adjuvant (N) | 2017-06-21 | 2017-09-11 | Liposomal Doxorubicin (20mg/m2) | 02 | N | DOXORUBICIN + METHOTREXATE | 100457965 |
| 190010459 | 190008299 | 1.7 | 77 | Neo-adjuvant (N) | 2020-01-09 | 2020-07-05 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101317669 |
| 190010554 | 190008300 | null | 21.6 | Curative (C) | 2021-12-20 | 2022-01-10 | MAP | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101448429 |
| 190010755 | 190008302 | 1.66 | 49.2 | Palliative (P) | 2019-10-26 | 2019-10-27 | CISPLATIN + FLUOROURACIL | null | null | EW EUROEWING 2012 ARM B VDC/IE | 101847115 |
| 190010853 | 190008303 | 0 | 56.9 | Neo-adjuvant (N) | 2021-03-30 | 2021-03-30 | OST Euramos 1 Closed Trial - A | 01 | null | OST A | 100377460 |
| 190007264 | 190008305 | 0 | 38.3 | Curative (C) | 2021-11-23 | 2021-11-23 | NIVOLUMAB | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 101834705 |
| 190009910 | 190008307 | null | null | Palliative (P) | 2016-05-09 | 2016-05-12 | Cyclophosphamide + Vincristine | 2 | N | CISPLATIN + GEMCITABINE | 101791109 |
| 190010117 | 190008309 | 1.66 | null | Curative (C) | 2021-07-05 | 2021-12-06 | OST Euramos 1 Closed Trial - M | 02 | N | OST M | 100494715 |
| 190010347 | 190008310 | 1.77 | 72 | null | 2016-05-22 | 2017-09-11 | MAP | 02 | null | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100457965 |
| 190010459 | 190008311 | 1.58 | 80.4 | null | 2020-02-01 | 2020-07-06 | CARBOPLATIN + ETOPOSIDE | 02 | N | DOXORUBICIN + METHOTREXATE | 101317669 |
| 190010554 | 190008312 | 1.7 | 63 | Curative (C) | 2021-12-05 | 2022-01-10 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 101448429 |
| 190010755 | 190008314 | 1.66 | 88.3 | null | 2020-01-02 | 2020-01-03 | Irinotecan + Temozolomide | null | null | DOXORUBICIN + OLARATUMAB | 101847115 |
| 190007264 | 190008316 | 0 | 48.5 | Curative (C) | 2021-12-26 | 2021-12-26 | Dox + HD Mtx (post PAM) | 02 | null | TRIAL | 101834705 |
| 190010347 | 190008319 | 1.63 | 95 | null | 2017-07-27 | 2017-09-12 | CAPECITABINE + OXALIPLATIN | 02 | N | DOXORUBICIN + METHOTREXATE | 100457965 |
| 190010459 | 190008320 | 1.65 | 76 | Neo-adjuvant (N) | 2020-07-19 | 2020-08-16 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101317669 |
| 190010755 | 190008323 | 1.75 | 62.2 | Palliative (P) | 2020-05-01 | 2020-06-01 | Trial Unspecified | null | null | CARBOPLATIN + FLUOROURACIL | 101847115 |
| 190007264 | 190008325 | 1.66 | 63.45 | Palliative (P) | 2021-12-26 | 2021-12-26 | Cisplatin + Gemcitabine (D 1 & 8) | 01 | null | IMATINIB | 101834705 |
| 190010755 | 190008331 | null | 86 | Adjuvant (A) | 2019-11-01 | 2020-06-15 | Cisplatin + Fluorouracil + RT 5day | 02 | N | TRIAL | 101847115 |
| 190007264 | 190008333 | 1.73 | 54.5 | Curative (C) | 2022-03-13 | 2022-03-26 | Cisplatin 7 day | 01 | null | BUSULFAN + MELPHALAN | 101834705 |
| 190010755 | 190008338 | 1.64 | 57 | Palliative (P) | 2020-07-11 | 2020-08-11 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101847115 |
| 190007264 | 190008340 | 1.56 | 74.4 | Curative (C) | 2022-03-30 | 2022-04-25 | Methotrexate High Dose (3g/m2) | 01 | null | METHOTREXATE | 101834705 |
| 190010755 | 190008344 | 1.65 | null | Palliative (P) | 2020-08-07 | 2020-09-09 | OST Euramos 1 Closed Trial - IE | 02 | N | IFOSFAMIDE | 101847115 |
| 190007264 | 190008345 | 1.59 | 75.2 | Palliative (P) | 2022-05-08 | 2022-05-21 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | null | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 101834705 |
| 190010755 | 190008347 | 1.58 | 31 | Curative (C) | 2021-04-21 | 2021-05-08 | EW EuroEwing 2012 Arm A VAI | 02 | null | CISPLATIN + DOXORUBICIN | 101847115 |
| 200003916 | 200003916 | null | null | null | null | 2020-03-20 | IPILIMUMAB + NIVOLUMAB | null | null | PEMBROLIZUMAB | 100025162 |
| 200003923 | 200003923 | null | null | null | null | 2020-05-28 | null | null | null | PEMBROLIZUMAB | 100862095 |
| 200003927 | 200003927 | null | null | null | null | 2014-03-08 | Doxorubicin 75mg/m2 | null | null | IPILIMUMAB + NIVOLUMAB | 101797531 |
| 200003931 | 200003931 | null | null | null | null | 2016-09-12 | IPILIMUMAB + NIVOLUMAB | null | null | IPILIMUMAB + NIVOLUMAB | 101504369 |
| 200003937 | 200003937 | 1.65 | 76.75 | Palliative (P) | 2019-01-05 | 2019-01-30 | null | 02 | N | TRIAL | 100232623 |
| 200003941 | 200003941 | null | null | Palliative (P) | 2020-06-12 | 2020-06-12 | Ipilimumab | 02 | null | NIVOLUMAB | 100465695 |
| 200003946 | 200003946 | null | null | null | null | 2019-03-20 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101151103 |
| 200003949 | 200003949 | null | null | Palliative (P) | 2017-08-15 | 2017-08-18 | BEP 3 day | 02 | N | PEMBROLIZUMAB | 101129964 |
| 200003974 | 200003974 | null | null | Palliative (P) | null | 2016-03-04 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 101617191 |
| 200003977 | 200003977 | 1.67 | 88.5 | null | null | 2020-12-02 | Trial Unspecified | null | null | DABRAFENIB + TRAMETINIB | 100852902 |